Pre-earnings options volume in Syndax (SNDX) is normal with calls leading puts 7:5. Implied volatility suggests the market is anticipating a move near 10.9%, or $1.50, after results are released. Median move over the past eight quarters is 3.9%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNDX:
- Syndax announces Revuforj, Niktimvo data accepted for presentation at ASH 2025
- SNDX Upcoming Earnings Report: What to Expect?
- Syndax Pharmaceuticals Launches Promising Phase 3 AML Study with Revumenib
- Syndax Pharmaceuticals’ Revumenib Study: A Potential Game-Changer in Leukemia Treatment
- Syndax Pharmaceuticals’ Axatilimab Study: A Potential Breakthrough for IPF Treatment